Why is Thyrocare Tech. falling/rising?

As of 11-Jul, Thyrocare Technologies Ltd is currently priced at 1,075.00, reflecting a decrease of 8.45 points or 0.78%. The stock has experienced a decline over the past two days, with a total drop of 1.47%. Despite this recent downturn, the stock reached a new 52-week high of Rs 1107.05 earlier in the day, indicating strong performance in the short term, as evidenced by a 6.33% increase over the past week and an impressive 65.65% rise over the past year. However, the stock's recent performance is tempered by a significant drop in delivery volume, which has fallen by 59.56% against the 5-day average, suggesting reduced investor participation. While the company has shown high management efficiency and positive growth in operating profit, concerns about poor long-term growth and high valuations, including a PEG ratio of 2.1, may be contributing to the stock's current price movement.
In the broader market context, Thyrocare's short-term performance has outpaced the Sensex, which has declined by 1.12% over the past week. The stock's ability to generate a 6.33% return in the same period highlights its relative strength compared to the benchmark. However, the overall market sentiment may be affecting investor confidence, especially given the high percentage of pledged promoter shares, which can exert additional downward pressure in a falling market. Despite the company's strong historical performance and positive results over the last five quarters, these risks could be influencing the stock's recent price decline.